Twist Bioscience (TWST) grants 26,200 RSUs to SVP Paula Green

Twist Bioscience Corp. (TWST) reported an equity award to a senior executive.

Rhea-AI Filing Summary

Twist Bioscience Corp. (TWST) reported an equity award to a senior executive. Officer Paula Green, the company’s SVP of Human Resources, received 26,200 shares of common stock in the form of a restricted stock unit (RSU) grant on 11/18/2025 at a stated price of $0, reflecting a compensatory award rather than an open‑market purchase.

The RSUs vest over four years, with 1/16 of the total vesting on each quarterly anniversary of November 20, 2025, subject to her continued service through each vesting date. Following this grant, Paula Green beneficially owns 168,387 shares of Twist Bioscience common stock, held directly.

Insider Trade Summary

Grant/Award: 26,200 shares

Grant/Award 1 txn

Insider Green Paula

Role SVP of Human Resources

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	26,200	$0.00	$0.00

Holdings After Transaction: Common Stock — 168,387 shares (Direct)

Footnotes (1)

1. F1. Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2025 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.

FAQ

What insider transaction did Twist Bioscience (TWST) report for Paula Green?

Twist Bioscience reported that SVP of Human Resources Paula Green received a 26,200-share RSU award of common stock on 11/18/2025 at a stated price of $0.

How do Paula Green’s RSUs at Twist Bioscience (TWST) vest?

The 26,200 RSUs vest over 48 months, with 1/16 of the total vesting on each quarterly anniversary of November 20, 2025, contingent on continued service.

What is Paula Green’s total Twist Bioscience (TWST) share ownership after this Form 4 transaction?

After the reported RSU grant, Paula Green beneficially owns 168,387 shares of Twist Bioscience common stock, held directly.

What is Paula Green’s role at Twist Bioscience (TWST)?

Paula Green is reported as an officer of Twist Bioscience, serving as the company’s SVP of Human Resources.

Does the reported Twist Bioscience (TWST) transaction involve derivative securities?

The filing’s detailed transaction relates to restricted stock units (RSUs) settled in common stock; no specific derivative securities are listed in Table II for this transaction.

Is this Twist Bioscience (TWST) Form 4 filed by more than one reporting person?

No. The filing indicates it is a Form filed by one reporting person, covering Paula Green only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/20/2025 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Paula

(Last) (First) (Middle)

C/O TWIST BIOSCIENCE CORPORATION

681 GATEWAY BLVD.

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Twist Bioscience Corp [ TWST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP of Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		26,200(1)	A	$0	168,387	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2025 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

	/s/ Kendra Fox, as Attorney-in-Fact for Paula Green	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.